Scientific Committee:
Lee Bacheler
Tibotec-Virco, USA

Nick Cammack
Roche Palo Alto, USA

François Clavel
Inserm U552, France

Bonaventura Clotet
Fundacio IRSI Caixa, Spain

John Coffin
National Cancer Institute-Frederick, USA

Richard Colonno
Bristol-Myers Squibb Company, USA

Richard D'Aquila
Vanderbilt University Medical Center, USA

Victor De Gruttola
Harvard School of Public Health, USA

John Erickson
Sequoia Pharmaceuticals, USA

Daria Hazuda
Merck Research Laboratories, USA

Victoria Johnson
University of Alabama at Birmingham, USA

Dale Kempf
Abbott Laboratories, USA

Joerg-Peter Kleim
GlaxoSmithKline, UK

Daniel Kuritzkes
Brigham and Women's Hospital, USA

Douglas Mayers
Boehringer Ingelheim Pharmaceuticals, Inc, USA

Thomas Merigan
Stanford University School of Medicine, USA

Luc Perrin
Geneva University Hospital, Switzerland

Rick Pesano
Pfizer Global Research and Development, USA

Christos Petropoulos
ViroLogic, Inc, USA

Deenan Pillay
Royal Free and University College Medical School, UK

Jonathan Schapiro
Stanford University, USA

Raymond Schinazi
Emory University/VA Medical Center, USA

Ronald Swanstrom
University of North Carolina Center for AIDS Research, USA

Mark Wainberg
McGill University AIDS Centre, Canada

Patrick Yeni
Hopital Bichat, France